HRT Financial’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
HRT Financial's HALO Position: Q2 2026 in Review
HRT Financial increased its Halozyme (HALO) stake by 111% in Q2 2026, buying an estimated $13.2M and bringing the position to 368,510 shares worth $28.8M. The position accounts for 0.05% of the portfolio, ranked #336.
HRT Financial first reported a position in HALO in Q3 2019 and has held it in 17 quarters since. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.
- HRT Financial held 368,510 shares of Halozyme worth $28.8M as of Q2 2026.
- HRT Financial bought 193,981 Halozyme shares in Q2 2026, an estimated $13.2M.
- Halozyme made up 0.05% of HRT Financial's portfolio in Q2 2026, its #336 holding.
- HRT Financial first reported a position in Halozyme in Q3 2019 and has held it in 17 quarters since.
- 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.
Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.